LOS ANGELES, CA — For thirty-one years, a construction plumber named Dennis worked with transite, the gray asbestos-cement pipe that contractors across the American West installed in everything from school boiler rooms to municipal water systems. Nobody handed him a respirator. Nobody told him the dust he inhaled daily was slowly embedding itself in the lining of his lungs. Last month, a Los Angeles County jury told his family that silence was worth $4.1 million.

The verdict, delivered in late January 2026, targeted a successor corporation that acquired the assets of a defunct transite manufacturer through a series of mid-1990s transactions. Defense attorneys argued the company bore no liability for products manufactured and sold decades before the acquisition. The jury disagreed.

What the Verdict Establishes About Successor Liability

The case hinged on a legal doctrine that has gained significant traction in California asbestos courts: successor liability for companies that continue to profit from a product line while distancing themselves from the health consequences it caused. According to coverage from Law360's asbestos litigation desk, California courts have increasingly scrutinized so-called "asset purchase" defenses, particularly when successor companies retained the brand name, customer relationships, or manufacturing knowledge associated with the original product.

Transite, once marketed under various trade names by manufacturers including Johns-Manville and its competitors, was a staple of mid-twentieth-century construction. The pipe combined Portland cement with chrysotile asbestos fibers, creating a material that was lightweight, corrosion-resistant, and, as courts have now established in hundreds of cases, deadly when cut, drilled, or abraded. Workers who handled it routinely — plumbers, pipefitters, HVAC installers, and demolition crews — inhaled fibers that can cause mesothelioma and other asbestos-related diseases-lung-cancer.org/asbestos-exposure/) decades after exposure.

The plaintiff's legal team argued that Dennis's diagnosis of pleural mesothelioma, confirmed in early 2024, was a direct consequence of his transite work on commercial construction sites throughout Southern California. Medical testimony placed his cumulative fiber exposure well above thresholds associated with disease onset.

Why This Ruling Matters Beyond One Family

Successor liability cases are among the most contested in asbestos litigation. Corporations that acquired defunct manufacturers' assets often argue they purchased equipment and facilities, not the legal obligations attached to products those manufacturers sold. What the courts have consistently recognized, however, is that this reasoning breaks down when the acquiring company continues to benefit economically from the predecessor's market position.

In my experience representing mesothelioma families, the successor liability question is where defendants invest the most resources, because a win on that issue can insulate an entire corporate structure from accountability. This verdict signals that California juries are increasingly skeptical of that insulation.

The $4.1 million award included compensatory damages for Dennis's medical expenses, lost wages, and pain and suffering, along with a separate allocation to his wife for loss of consortium. According to data compiled by LexisNexis asbestos litigation analysts, California mesothelioma verdicts in cases involving asbestos-cement products have averaged between $3 million and $6 million over the past three years, placing this outcome squarely within the established range.

The legal landscape for asbestos victims in California has been shaped by decades of precedent, including the state's specific statute of limitations framework under California Code of Civil Procedure Section 340.2, which grants plaintiffs one year from the date they knew or reasonably should have known of their asbestos-related illness to file suit.

$4.1MJury verdict awarded to a retired plumber's family after transite pipe exposure caused pleural mesothelioma

What This Means for Workers Who Handled Transite

If you or someone in your family worked in construction, plumbing, or building maintenance between the 1950s and 1990s, there is a meaningful chance transite was part of that work environment. The pipe was ubiquitous in schools, hospitals, industrial facilities, and residential construction across the United States. Demolition and renovation workers face ongoing exposure even today, as older buildings are torn down or retrofitted.

A mesothelioma diagnosis following transite exposure does not automatically translate into a clear legal path, but the options are broader than most families initially realize. Depending on the specific manufacturers involved, claims may be pursued through civil litigation against solvent successor companies, through asbestos bankruptcy trust funds established by manufacturers that have since reorganized, or through both channels simultaneously. The RAND Corporation has documented that more than 60 asbestos bankruptcy trusts have been established since the 1980s, collectively holding billions of dollars in reserved compensation for qualified claimants.

Families navigating this terrain should consult attorneys who specialize specifically in asbestos litigation. The legal answers resource at mesothelioma-lung-cancer.org provides an overview of how these claims are typically structured, and families can connect with qualified attorneys through the mesothelioma lawyer directory to understand their specific options before statutes of limitations close.

For Dennis's family, the verdict won't undo the diagnosis. But it establishes, once again, that decades of corporate distance from a product's consequences do not erase the obligation to the workers who paid the price.


Attorney Advertising. Past results do not guarantee future outcomes. Every case is unique. The verdicts and settlements described are not a guarantee of similar results. Every case is different.